These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 25240098

  • 1. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, Wilkinson SR, Kaiser M.
    Eur J Med Chem; 2014 Nov 24; 87():79-88. PubMed ID: 25240098
    [Abstract] [Full Text] [Related]

  • 2. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, O'Shea IP, Wilkinson SR, Kaiser M.
    Eur J Med Chem; 2015 Oct 20; 103():325-34. PubMed ID: 26363868
    [Abstract] [Full Text] [Related]

  • 3. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, O'Shea IP, Wilkinson SR, Kaiser M, Chatelain E, Ioset JR.
    Bioorg Med Chem; 2015 Oct 01; 23(19):6467-76. PubMed ID: 26344593
    [Abstract] [Full Text] [Related]

  • 4. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, Chatelain E, Kaiser M, Wilkinson SR, McKenzie C, Ioset JR.
    J Med Chem; 2012 Jun 14; 55(11):5554-65. PubMed ID: 22550999
    [Abstract] [Full Text] [Related]

  • 5. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, Kaiser M, Chatelain E, Ioset JR.
    Bioorg Med Chem; 2013 Nov 01; 21(21):6600-7. PubMed ID: 24012457
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, Kaiser M.
    Eur J Med Chem; 2017 Sep 29; 138():1106-1113. PubMed ID: 28763645
    [Abstract] [Full Text] [Related]

  • 8. In vitro antiparasitic activity of new thiosemicarbazones in strains of Trypanosoma cruzi.
    Moreno-Rodríguez A, Salazar-Schettino PM, Bautista JL, Hernández-Luis F, Torrens H, Guevara-Gómez Y, Pina-Canseco S, Torres MB, Cabrera-Bravo M, Martinez CM, Pérez-Campos E.
    Eur J Med Chem; 2014 Nov 24; 87():23-9. PubMed ID: 25238291
    [Abstract] [Full Text] [Related]

  • 9. Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.
    Papadopoulou MV, Trunz BB, Bloomer WD, McKenzie C, Wilkinson SR, Prasittichai C, Brun R, Kaiser M, Torreele E.
    J Med Chem; 2011 Dec 08; 54(23):8214-23. PubMed ID: 22023653
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antitrypanosomal activities of novel pyridylchalcones.
    Bhambra AS, Ruparelia KC, Tan HL, Tasdemir D, Burrell-Saward H, Yardley V, Beresford KJM, Arroo RRJ.
    Eur J Med Chem; 2017 Mar 10; 128():213-218. PubMed ID: 28189085
    [Abstract] [Full Text] [Related]

  • 11. Abietane-Type Diterpenoid Amides with Highly Potent and Selective Activity against Leishmania donovani and Trypanosoma cruzi.
    Pirttimaa M, Nasereddin A, Kopelyanskiy D, Kaiser M, Yli-Kauhaluoma J, Oksman-Caldentey KM, Brun R, Jaffe CL, Moreira VM, Alakurtti S.
    J Nat Prod; 2016 Feb 26; 79(2):362-8. PubMed ID: 26849852
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, Ashworth R, Wilkinson SR, Kaiser M, Andriani G, Rodriguez A.
    Future Med Chem; 2013 Oct 26; 5(15):1763-76. PubMed ID: 24144412
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
    DA Silva CF, Daliry A, DA Silva PB, Akay S, Banerjee M, Farahat AA, Fisher MK, Hu L, Kumar A, Liu Z, Stephens CE, Boykin DW, Correia Soeiro MD.
    Parasitology; 2011 Dec 26; 138(14):1863-9. PubMed ID: 21902869
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment In Vivo Assay.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, Mazzeti AL, Gonçalves KR, Mendes PF, Bahia MT.
    Antimicrob Agents Chemother; 2017 May 26; 61(5):. PubMed ID: 28242662
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study.
    Assunção ELF, Carvalho DB, das Neves AR, Kawasoko Shiguemotto CY, Portapilla GB, de Albuquerque S, Baroni ACM.
    ChemMedChem; 2020 Nov 04; 15(21):2019-2028. PubMed ID: 32729242
    [Abstract] [Full Text] [Related]

  • 19. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
    Saccoliti F, Madia VN, Tudino V, De Leo A, Pescatori L, Messore A, De Vita D, Scipione L, Brun R, Kaiser M, Mäser P, Calvet CM, Jennings GK, Podust LM, Costi R, Di Santo R.
    Eur J Med Chem; 2018 Aug 05; 156():53-60. PubMed ID: 30006174
    [Abstract] [Full Text] [Related]

  • 20. 1,2,3-Triazole-based analogue of benznidazole displays remarkable activity against Trypanosoma cruzi.
    de Andrade P, Galo OA, Carvalho MR, Lopes CD, Carneiro ZA, Sesti-Costa R, de Melo EB, Silva JS, Carvalho I.
    Bioorg Med Chem; 2015 Nov 01; 23(21):6815-26. PubMed ID: 26476667
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.